Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    October 2018

  1. Enzalutamide in Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;379:1380-1381.
    PubMed     Text format    


  2. BREGNI G, Rebuzzi SE, Fornarini G
    Enzalutamide in Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;379:1380-1.
    PubMed     Text format    


  3. ANKER MS, Lehmann LH, Ander SD
    Enzalutamide in Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;379:1380.
    PubMed     Text format    


    September 2018
  4. VEDULA R, Vaidya A, Galetta K, Laubach J, et al
    A Sticky Situation.
    N Engl J Med. 2018;379:e22.
    PubMed     Text format    


  5. ANTONARAKIS ES
    Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer.
    N Engl J Med. 2018;379:1087-1089.
    PubMed     Text format    


    August 2018
  6. VICKERS A, Ehdaie B
    MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589.
    PubMed     Text format    


  7. MARTINI A, Cumarasamy S, Tewari AK
    MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589.
    PubMed     Text format    



  8. MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589-590.
    PubMed     Text format    


    June 2018
  9. RACHNER TD, Tsourdi E, Hofbauer LC
    Apalutamide and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018;378:2541-2.
    PubMed     Text format    



  10. Apalutamide and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018;378:2541-2542.
    PubMed     Text format    


  11. HUSSAIN M, Fizazi K, Saad F, Rathenborg P, et al
    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;378:2465-2474.
    PubMed     Text format     Abstract available


  12. BEAVER JA, Kluetz PG, Pazdur R
    Metastasis-free Survival - A New End Point in Prostate Cancer Trials.
    N Engl J Med. 2018;378:2458-2460.
    PubMed     Text format    


  13. SMITH MR
    Progress in Nonmetastatic Prostate Cancer.
    N Engl J Med. 2018;378:2531-2532.
    PubMed     Text format    


    May 2018
  14. BARRY MJ, Rosenkrantz AB
    MRI-Targeted versus Ultrasonography-Guided Biopsy for Suspected Prostate Cancer.
    N Engl J Med. 2018;378:1835-1836.
    PubMed     Text format    


  15. SMITH TJ, Loprinzi CL, Deville C
    Oxybutynin for Hot Flashes Due to Androgen Deprivation in Men.
    N Engl J Med. 2018;378:1745-1746.
    PubMed     Text format    


    April 2018
  16. RODRIGUEZMORENO JF, GarciaDonas J
    Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653.
    PubMed     Text format    


  17. ABATE-SHEN C
    Prostate Cancer Metastasis - Fueled by Fat?
    N Engl J Med. 2018;378:1643-1645.
    PubMed     Text format    



  18. Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653-1654.
    PubMed     Text format    


    March 2018
  19. KASIVISVANATHAN V, Rannikko AS, Borghi M, Panebianco V, et al
    MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018 Mar 18. doi: 10.1056/NEJMoa1801993.
    PubMed     Text format     Abstract available


    February 2018
  20. CHEN D, Ayala GE
    Innervating Prostate Cancer.
    N Engl J Med. 2018;378:675-677.
    PubMed     Text format    


  21. SMITH MR, Saad F, Chowdhury S, Oudard S, et al
    Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018 Feb 8. doi: 10.1056/NEJMoa1715546.
    PubMed     Text format     Abstract available


  22. SARTOR O, de Bono JS
    Metastatic Prostate Cancer.
    N Engl J Med. 2018 Feb 7. doi: 10.1056/NEJMra1701695.
    PubMed     Text format    


    October 2017
  23. FIZAZI K, Chi KN
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1697-8.
    PubMed     Text format    


  24. ISMAILI N, Guessous F
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1695-6.
    PubMed     Text format    


  25. TANNOCK IF
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1695.
    PubMed     Text format    


  26. DE BONO J, Eisenberger M, Sartor O
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1694-5.
    PubMed     Text format    


  27. JAMES ND, Spears MR, Sydes MR
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1696-7.
    PubMed     Text format    


    September 2017
  28. SHARMA V, Karnes RJ
    Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1302.
    PubMed     Text format    



  29. Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1301-1303.
    PubMed     Text format    


  30. WALLIS CJD, Klotz L
    Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1301-2.
    PubMed     Text format    


    July 2017
  31. LOGOTHETIS CJ
    Improved Outcomes in Men with Advanced Prostate Cancer.
    N Engl J Med. 2017;377:388-390.
    PubMed     Text format    


  32. HAYMART MR, Miller DC, Hawley ST
    Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?
    N Engl J Med. 2017;377:203-206.
    PubMed     Text format    


  33. WILT TJ, Jones KM, Barry MJ, Andriole GL, et al
    Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:132-142.
    PubMed     Text format     Abstract available


    June 2017
  34. PINSKY PF, Prorok PC, Kramer BJ
    Prostate Cancer Screening.
    N Engl J Med. 2017;376:2402.
    PubMed     Text format    


  35. WALSH PC
    Prostate Cancer Screening.
    N Engl J Med. 2017;376:2401-2.
    PubMed     Text format    


  36. FIZAZI K, Tran N, Fein L, Matsubara N, et al
    Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
    N Engl J Med. 2017 Jun 4. doi: 10.1056/NEJMoa1704174.
    PubMed     Text format     Abstract available


  37. JAMES ND, de Bono JS, Spears MR, Clarke NW, et al
    Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    N Engl J Med. 2017 Jun 3. doi: 10.1056/NEJMoa1702900.
    PubMed     Text format     Abstract available


    March 2017
  38. PINSKY PF, Prorok PC, Kramer BS
    Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
    N Engl J Med. 2017;376:1285-1289.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: